scPharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Scpharmaceuticals

09/11/2022 22:54

* scPharmaceuticals Inc  SCPH.OQ  reported a quarterly
adjusted
loss of 37 cents​​ per share for the quarter ended in September.
The mean expectation of four analysts for the quarter was for a
loss of 38 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * scPharmaceuticals Inc's reported EPS for the quarter was a
loss
of 37 cents​.
    * The mean earnings estimate of analysts had risen by
about 5.9%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * scPharmaceuticals Inc shares had fallen by 13.7% this
quarter and gained 12.2% so far this year.
    * The company reported a quarterly loss of $10.16 million.
    * Wall Street's median 12-month price target for
scPharmaceuticals
Inc is $13.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 10:54 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.38          -0.37          Beat
 Jun. 30 2022      -0.30          -0.35          Missed
 Mar. 31 2022      -0.31          -0.28          Beat
 Dec. 31 2021      -0.34          -0.27          Beat